Medication Monitoring. 1. Every Child shall have a mental health assessment with a DSM-based diagnosis documented in the Child’s Case File prior to being prescribed a Psychotropic Medication. In the case of a Child who comes into XX xxxxxx care with an existing Psychotropic Medication prescription, CD may continue to administer such medication until the necessary evaluations have been made.
2. Every Child prescribed a Psychotropic Medication shall have medical examinations as indicated by the current Bright Futures/American Academy of Pediatrics “Recommendation for Preventive Pediatric Health Care,” or “periodicity schedule,” or more frequently if recommended by the prescriber.
3. Every Child prescribed a Psychotropic Medication for ongoing use (more than a single dose) shall have, documented in the Child’s Case File, monitoring appointments with a prescriber at least every three months, or more frequently if indicated by the prescriber.
4. Every Child prescribed a Psychotropic Medication shall receive concurrent non- pharmacological treatment at the frequency and duration recommended by the prescriber.
Medication Monitoring. Face-to-face, one-on-one cueing, observing, and encouraging a Medicaid-enrolled individual to take medications as prescribed. Also includes reporting back to persons licensed to perform medication management services for the direct benefit of the Medicaid-enrolled individual. This activity may take place at any location and for as long as it is clinically necessary. This service is designed to facilitate medication compliance and positive outcomes. Enrollees with low medication compliance history or persons newly on medication are most likely to receive this service. This service is provided by or under the supervision of a Mental Health Professional. Time spent with the Enrollee is the only direct service reportable component of this modality.
Medication Monitoring. Contractor shall implement mechanisms to monitor the safety and effectiveness of medication practices. The monitoring mechanism shall be under the supervision of a person licensed to prescribe or dispense prescription drugs. Monitoring shall occur at least annually.
Medication Monitoring. Medication monitoring will be conducted as needed, and at least every 60 days, by the client’s treating physician/psychiatrist. The criteria reviewed will include:
5.3.3.1. Appropriateness of medications ordered based on documented and presenting symptoms and diagnosis.
5.3.3.2. Appropriateness of dosing and titration of individual medications.
5.3.3.3. Appropriateness of monitoring of individual medications.
5.3.3.4. Cost-effectiveness of prescribing patterns. The physician/psychiatrist will report changes, based on his or her review, to the Program Director and interdisciplinary team, as well as in writing; the review will be documented immediately in the client’s chart. Results and changes will also be reported to the referring county as needed or requested. In addition to monthly medication monitoring and review, all clients will have access to their treating physician/psychiatrist as needed.
Medication Monitoring. Prescription narcotic medications are not permitted at We Steel Rise. All other prescriptions are allowed only if they are prescribed to you by a doctor and are taken as prescribed. Medications are not shared with any other resident. Residents are responsible for taking care of their own prescribed medications. We Steel Rise does not administer medications. Morphine and methadone are not permitted. You may not consume anything nor bring to the property anything that contains alcohol, including but not limited to, over the counter medications and mouth wash. All residents are expected to provide an accurate accounting of the medications they bring to We Steel Rise. All medications must be listed on Resident Medication Record with other pertinent information. At any time, staff deems necessary, medications may be counted to confirm the accuracy of dosages taken. Any changes in the dosage must be confirmed in writing or by telephone to staff from the issuing doctor. Do not leave medications out where they are in the open or unprotected. Keep in a dresser drawer or with you at all times. You are responsible for the control of your medications and any deviations are considered abuse. Abuse of medications will be considered a relapse and residency will be terminated.
Medication Monitoring. The AMH+ practice or CMA must conduct medication monitoring, including regular medication reconciliation (conducted by the appropriate care team member) and support of medication adherence. A community pharmacist at the CIN level, in communication with the AMH+ practice or CMA, may assume this role.
